Family profileClinically reviewed · indexable

Restylane

Galderma

A family-level profile connecting named Restylane catalogue variants with Galderma's current product-family material.

Evidence status: Evidence dossier · named clinical review approved

Identity record

What is recorded

v2026.08.15.1
Record type
Source-linked family profile
Recorded maker
Galderma
Classification
Dermal filler
Material identity
hyaluronic acid
Snapshot date
14 August 2026

Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.

Jurisdiction map

What each market source establishes

Ready for clinical review

Product names and regulatory context do not travel automatically between countries. Each row below is limited to its named source market.

US

United States

Regulator record

Named record

Restylane injectable gel · Restylane collection

The FDA PMA database records Restylane injectable gel under P040024, and Galderma documents the current US family and hyaluronic-acid technology context.

Limit: The PMA has many supplements; family evidence does not verify each catalogue spelling, variant, or current label.

RESTYLANE injectable gel — PMA P040024Restylane science and technology

Catalogue relationship

Matched identities and variants

9 matches

Provenance

Sources checked for this profile

3 sources · checked 14 August 2026
  1. Manufacturer

    1. Restylane science and technology

    Galderma · United States

    Open source ↗

    Supports: Restylane family identity, named technologies, and hyaluronic-acid material class.

  2. Regulator

    2. FDA-approved dermal fillers

    U.S. Food and Drug Administration · United States

    Open source ↗

    Supports: Regulatory-method context and the requirement to verify individual filler records and labels.

  3. Regulator

    3. RESTYLANE injectable gel — PMA P040024

    U.S. Food and Drug Administration · United States

    Open source ↗

    Supports: The original US Restylane PMA record, Q-Med applicant identity, generic device class, and supplement history.

Claim ledger

Every statement has a boundary

2 review claims
  1. 1

    Identity

    Restylane is a family identity spanning multiple named catalogue variants.

    Scope: Each variant remains a separate identity requiring product-specific evidence for variant-level claims.

    Evidence: RESTYLANE injectable gel — PMA P040024Evidence: Restylane science and technology
  2. 2

    Material / active name

    The linked family sources place Restylane in the hyaluronic-acid dermal-filler class.

    Scope: This does not state the concentration, cross-linking, lidocaine content, or indication of a specific variant.

    Evidence: RESTYLANE injectable gel — PMA P040024Evidence: Restylane science and technology

Use boundary

What this record does not establish

  • Regulatory statusOnly within a source's named jurisdiction; family-profile review does not establish status elsewhere.
  • Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
  • Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
  • Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.

Separate reference from record-keeping

Document the exact product and lot actually used

Aesthetic Pass records treatment identity, lot information, photos, and injection maps. The atlas itself never chooses a product or treatment.

Explore traceability